Table 3.
Product | Baseline | Aqueous fluid | Aqueous gel | Lipid fluid | Lipid gel |
---|---|---|---|---|---|
Brushesa | - | 1 | 0.63* (0.4, 0.9) | 0.14* (0.09, 0.2) | 0.77 (0.4, 1.1) |
Biopsiesa | - | 1 | 0.90 (0.5, 1.4) | 0.44* (0.2, 0.7) | 1.51 (0.9, 2.3) |
Denudationb | 1 | 1.7 (0.7, 3.9) | 1.4 (0.6, 3.1) | 1.0 (0.4, 2.4) | 1.6 (0.7, 3.7) |
Log p24c,d | 0 | −0.30 (−0.89, 0.30) | −0.80** (−1.41, −0.20) | 0.68* (0.08, 1.28) | 0.01 (−0.59, 0.60) |
p < 0.05, **p < 0.01.
Multi-level analysis, in comparison with aqueous fluid product reference value of 1.
Multi-level analysis, in comparison to baseline (no product) reference value of 1.
Mixed effect model, in comparison to baseline (no product) reference value of 0. Calculation based on average of 1,000 bootstrap samples.
Negative Log p24 values indicate protection from HIV infection compared to no product control; positive values indicate increased HV infectivity.